Adjuvant pembrolizumab treatment improves survival in patients with advanced soft tissue sarcoma of the limb
Adding treatment with pembrolizumab to standard of care in patients with advanced soft tissue sarcoma of the limb appears to significantly improve disease-free survival, researchers reported on Nov…. read more.
